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Impaired Neonatal Immunity and
Infection Resistance Following Fetal
Growth Restriction in Preterm Pigs
Ole Bæk †, Shuqiang Ren †, Anders Brunse, Per Torp Sangild and Duc Ninh Nguyen*
Section for Comparative Pediatrics and Nutrition, University of Copenhagen, Copenhagen, Denmark
Background: Infants born preterm or small for gestational age (SGA, due to fetal growth
restriction) both show an increased risk of neonatal infection. However, it remains unclear
how the co-occurrence of preterm birth and SGA may affect neonatal immunity and
infection risk. We hypothesized that fetal growth restricted (FGR) preterm newborns
possess impaired immune competence and increased susceptibility to systemic infection
and sepsis, relative to corresponding normal birth weight (NBW) newborns.
Methods: Using preterm pigs as a model for preterm infants, gene expression in
lipopolysaccharide (LPS) stimulated cord blood was compared between NBW and FGR
(lowest 25% birth weight percentile) preterm pigs. Next, clinical responses to a systemic
Staphylococcus epidermidis (SE) challenge were investigated in newborn FGR and NBW
preterm pigs. Finally, occurrence of spontaneous infections were investigated in 9 d-old
FGR and NBW preterm pigs, with or without neonatal antibiotics treatment.
Results: At birth, preterm FGR piglets showed diminished ex vivo cord blood responses
to LPS for genes related to both innate and adaptive immunity, and also more severe
septic responses following SE infection (e.g., higher blood lactate, decreased blood pH,
neutrophil and platelet counts, relative to NBW pigs). After 9 d, FGR pigs had higher
incidence and severity of spontaneous infections (e.g., higher bacterial densities in the
bone marrow), increased regulatory T cell numbers, reduced neutrophil phagocytosis
capacity, and impaired ex vivo blood gene responses to LPS, especially when receiving
neonatal antibiotics.
Conclusion: FGR at preterm birth is associated with poor immune competence,
impaired infection resistance, and greater sepsis susceptibility in the immediate postnatal
period. Our results may explain the increased morbidity and mortality of SGA preterm
infants and highlight the need for clinical vigilance for this highly sensitive subgroup of
preterm neonates.
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BACKGROUND
Preterm infants (born before 37 weeks of gestation) are at a
higher risk of life threatening infections than their term born
counterparts, risk increasing with lower gestational age (1–3).
The causes of this are multifaceted, including an immature
immune system, comorbidities related to prematurity, and
iatrogenic interventions during hospital admission (3, 4). In
addition, intrauterine complications that could lead to premature
birth, may also affect nutrient supply to the fetus. If fetal growth
is severely affected, infants could be born small for gestational
age (SGA), defined as a birth weight in the lower 10th percentile
of the expected weight for gestational age. Infants born SGA,
whether preterm or not, show a higher postnatal mortality than
infants of adequate birth weight (5). They also display lower
blood neutrophil counts at birth and less responsive leucocytes to
ex vivo infectious challenges (6, 7). Some studies even suggested
that this impaired immune status may persist for years after birth
with SGA (8, 9). From animal studies, low birth weight following
term birth has been correlated with negative long term effects
on growth as well as systemic and gut immune functions (10–
13). The possible effects of being both premature and SGA on
immune development and infection risks during the first few
days of life, remain elusive. Few observational studies indicate
an association between SGA and increased mortality and sepsis
in preterm infants (3, 14–16) and cord blood from SGA preterm
infants may be less responsive to ex vivo lipopolysaccharide (LPS)
challenge (17). Regardless, the separate effects of prematurity and
SGA remain unclear because both overlapping and independent
factorsmay predispose to preterm delivery and growth restriction
at birth (e.g., maternal infection/inflammation, poor placental
function, reduced blood supply/oxygenation, or genetic factors).
Systemic infection in preterm infants is difficult to diagnose
due to the lack of precise biomarkers and poor sensitivity of blood
culture assays using small blood volumes (18–20). Therefore,
empirical antibiotics are used for a majority of preterm infants
in the days after birth despite that only a fraction these infants
may indeed be infected (21, 22). Such antibiotic treatments in
the neonatal period may affect gut bacterial colonization and
immune development early in life, although the evidence from
infants are limited. In preterm pigs, neutrophil status is affected
by prophylactic oral antibiotics (23). In term pigs, short term
neonatal antibiotics altered immune response several weeks after
exposure, even though the changes to gut microbiota disappeared
after 1 week (24). In term infants, early life antibiotic use is
associated with later development of asthma and eczema (25, 26),
but such studies are of limited value for the special condition
of preterm birth. More information is required on the possible
interacting effects of antibiotics treatment and growth restriction
on immune development in the early life of preterm neonates.
Preterm pigs are acknowledged as a clinically relevant model
for preterm infants as they show many complications similar to
preterm infants, including impaired immunity, immature organ
systems, and increased susceptibility to sepsis and necrotizing
enterocolitis (27, 28). Planned delivery by preterm cesarean
section on pregnant sows makes it possible to study factors
related to reduced gestational age at birth (e.g., developmental
immaturity), independent from the pathological factors that
may predispose to and affect outcomes in preterm infants,
besides reduced fetal age. Using the preterm pig model, we
hypothesized that fetal growth restriction (FGR) would further
impair immune competence and increase the risk of systemic
infection and sepsis in preterm pigs, relative to preterm pigs
with a normal body weight (NBW) for their gestational age. FGR
was defined as the lowest 25% birth weight percentile to include
both moderately and extremely growth restricted neonates in
evaluating immune status, spontaneous infections and responses
to infection challenges, with or without antibiotic treatment just
after preterm birth. Different from our previous longer term
study on systemic immune status in FGR and NBW preterm pigs
with optimal feeding to avoid clinical complications (10), we now
focused on the in vitro and in vivo responses to systemic infection
in the first week after preterm birth when both preterm pigs and
infants are highly sensitive to infections.
METHODS
All animal experiments were approved by the Danish National
Committee on Animal Experimentation (2014-15-0201-00418).
We performed three experiments to determine the immune
competence, sepsis outcomes following infection challenges and
spontaneous infection in FGR preterm pigs. All pigs were of the
same race (Duroc x Yorkshire x Danish Landrace) and delivered
by cesarean section at the same gestational age (106 days, ∼90%
gestation), probably reflecting an immune system development
of human preterm infants born at 24–28 weeks of gestation,
as described previously (27). Within each litter across these
experiments, FGR animals were defined as those in the lower
25th percentile for birth weight, while remaining animals were
designated as normal birth weight (NBW).
Experiment 1
In order to explore immune competence at birth, cord blood
was collected from 81 preterm pigs (21 FGR, 60 NBW) across
4 litters from the umbilical cord at delivery. Fresh blood was then
immediately used for ex vivo stimulation assay as described later.
Experiment 2
Fifty-seven preterm pigs across 5 litters were delivered,
immediately resuscitated in heated and oxygenated incubators
(2 L/min) and manual ventilation was performed if deemed
necessary. While still affected by anesthesia, each pig was
fitted with an umbilical arterial catheter (4F, Portex, UK)
for arterial blood sampling and administration of parenteral
nutrition. Shortly after birth, 38 animals were infused with
live Staphylococcus epidermidis (SE) bacteria (1∗108 − 5∗109
colony forming units/kg) via the umbilical catheter, as previously
described (29). The pigs were stratified by the predefined FGR
criteria, resulting in two groups SE-FGR (n = 9) and SE-
NBW (n = 29). The remaining pigs received the same volume
of control saline, and were not divided by birth weight due
to the low number (CON, n = 19). Following administration
of SE or saline, pigs were closely monitored for the next
24 h for signs of sepsis, pain, and circulatory collapse. If
severe symptoms appeared, animals were euthanized ahead of
schedule according to predefined, humane endpoints. During
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the experiment, animals were kept on total parenteral nutrition
(Kabiven, Fresenius-Kabi, Swenden, 6 mL/kg/h). Blood samples
were drawn from the umbilical catheter 6, 12, and 24 h after
inoculation and used for hematology and arterial blood gas
analysis, as described later. After 24 h, all pigs were euthanized
by intracardial injection of pentobarbital.
Experiment 3
Preterm pigs (n= 127) across 7 litters were delivered by cesarean
section, resuscitated and fitted with umbilical catheters as in Exp
2. In addition, the pigs were fitted with an orogastric feeding
tube (6F, Portex, UK) for administration of enteral nutrition
and antibiotics. A proportion of animals (n = 30) received oral
antibiotics within the first 4 days of life. All pigs were reared
until postnatal day 9. The animals were divided by birth weight
(NBW or FGR) and antibiotic use (CON or AB), resulting in four
groups: NBW-CON (n = 78), FGR-CON (n = 19), NBW-AB (n
= 22), and FGR-AB (n= 8).
The pigs were weighed daily and clinically assessed twice a day,
for signs of illness or pain. If necessary, a pain relief drug was
given as an intramuscular injection of meloxicam or butorphanol
(Metacam, Denmark or Torbugesic, Finland). According to
predefined humane endpoints, animals were euthanized ahead
of schedule if they exhibited treatment resistant pain or severe
morbidities. The pigs were fed, via the orogastric catheter,
increasing amounts of infant formula (16–112 mL/kg/day). Pigs
received different bovine milk based diets, that were prepared
daily, as described previously (30). The enteral nutrition was
supported by decreasing amount of parenteral nutrition (same
formulation as in Exp 2, from 6 mL/kg/h at birth to 2 mL/kg/h
on days 6–9). For NBW-AB and FGR-AB pigs, a combination of
amoxicillin with clavulanic acid (50/25 mg/kg, Bioclavid, Sandoz
GmbH, Austria) and neomycin (50 mg/kg, Neomay, ScanVet,
Denmark) was given through the orogastric tube twice daily for
the first 4 days. Blood samples for the evaluation of hematology,
neutrophil phagocytosis, T cell profiling, and gene expression
analysis were drawn from the umbilical catheter on day 5, 7, and
9, after which all pigs were euthanized by intercardial injection of
pentobarbital. After euthanasia the left hind leg was severed, the
femur head dissected and immersed in 70% ethanol for 10min,
and a bone marrow biopsy was collected in a sterile manner, for
bacterial enumeration.
Immune Cell Characterization
Hematology and immune cell counts on all blood samples from
Exp 2 and 3 were performed on an Advia 2120 hematology
system (Siemens Healthcare Diagnostics, USA). In Exp 2 arterial
blood gas analysis was performed using a GEM Premier 3000
(Instrumentation Laboratory, USA).
In Exp 3, T cell characterization was performed as previously
described (31). Briefly, blood leucocytes were stained with
fluorescent antibodies against porcine CD3, CD4, CD8, and
FOXP3. Leucocytes were then analyzed using a BD Accuri
C6 flow cytometer (BD Biosciences, USA). T cell subsets
were defined as follows: T cells (CD3+ lymphocytes), CD4
positive T cells (CD3+CD4+CD8− lymphocytes), CD8 positive
T cells (CD3+CD4−CD8+ lymphocytes) and regulatory T cells
(CD3+CD4+FOXP3+ lymphocytes).
Whole Blood Stimulation and Neutrophil
Phagocytosis Assays
Ex vivo whole blood stimulation and leucocyte gene expression
was performed in Exp 1 and in a subgroup of Exp 3 (NBW-
CON, n = 25; FGR-CON n = 5; NBW-AB, n = 19; FGR-
AB, n = 7). Briefly, fresh whole blood was incubated at 37◦C
for 5 h with or without 1µg/ml LPS added. After stimulation,
whole blood was stabilized with a mixture of lysis/binding
solution concentrate and isopropanol (MagMax 96 blood RNA
isolation kit, Thermofisher, Roskilde, Denmark), and stored
at −80◦C until RNA extraction. RNA was extracted and
prepared for quantitative polymerase chain reaction (qPCR)
as described elsewhere (10). Using a LightCycler 480 system
(Roche, Switzerland) and a commercial qPCR kit (QuantiTect
SYBR Green PCR Kit, Qiagen, Netherlands), gene expressions
were determined for a panel of 23 genes related to innate
and adaptive immunity, as well as cellular metabolism. The
genes and corresponding primers are shown in Table 1, primers
were designed using the Genes database and Primer-BLAST
software (both National Center for Biotechnology Information,
USA). HPRT1 was used as a housekeeping gene. If a gene
in a sample could not be detected by qPCR the sample was
rerun, if no expression could be obtained the gene was censored
from analysis. If HPRT1 could not be determined, the entire
sample was censored from analysis. Differences in expression
of specific genes were calculated relative to the expression of
the housekeeping gene, done separately in LPS and non-LPS
stimulated samples.
In the same subgroup of Exp 3, neutrophil phagocytic function
was assessed using commercial fluorescently labeled E. coli
kit (pHrodo, ThermoFisher, Roskilde, Denmark), as described
previously (32). In short, whole blood was incubated with
the fluorescent bacteria, and thereafter analyzed on the above
mentioned flow cytometer. Neutrophils were identified and
phagocytic rate was defined as the fraction of neutrophils with
internalized bacteria and phagocytic capacity, as the median
fluorescent index of neutrophils with internalized bacteria.
Microbiology
In Exp 3 we assessed spontaneous bacterial accumulation in the
bone marrow. Bone marrow homogenate was serially diluted,
plated out on blood agar plates and incubated for 24 h at 37◦C.
Colonies were counted and bacterial density was assessed as
colony forming units per milliliter of bone marrow homogenate.
Later, bacteria were identified at species level by Matrix Assisted
Laser Desorption/Ionization time of flight mass spectroscopy, as
previously described (23).
Statistics
Stata 14.2 (StataCorp, Texas, USA) was used for all calculations.
For all comparisons, we used a linear mixed effect model, with
relevant intervention as the fixed factor and litter as the random
factor. If a variable could not conform to normal distribution
after logistic transformation it was assessed by a non-parameteric,
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TABLE 1 | List of genes and primers used in gene expression analysis.
Protein Gene Forward sequence (5′-3′) Reverse sequence (5′–3′) Amplicon length
CXC chemokine ligand 9 CXCL9 GAAAAGCAGTGTTGCCTTGCT TGATGCAGGAACAACGTCCAT 98
CXC chemokine ligand 10 CXCL10 ATCATCCCGAGCTGTTGAGC CCAGGACTTGGCACATTCAC 94
GATA binding protein 3 GATA3 ACCCCTTATTAAGCCCAAGC TCCAGAGAGTCGTCGTTGTG 92
Hypoxia inducible factor 1 alpha HIF1A TGTGTTATCTGTCGCTTTGAGTC TTTCGCTTTCTCTGAGCATTC 96
Hexokinase 1 HK1 TTTCCCTTGTCGGCAATCCA CCTCCACTCCGCTTGCTTTA 80
Hypoxanthine phosphoribosyltransferase 1 HPRT1 TATGGACAGGACTGAACGGC ACACAGAGGGCTACGATGTG 75
Interferon gamma IFNG AGCTTTGCGTGACTTTGTGT ATGCTCCTTTGAATGGCCTG 247
Interleukin 2 IL2 AAGCTCTGGAGGGAGTGCTA CAACAGCAGTTACTGTCTCATCA 159
Interleukin 4 IL4 GTACCAGCAACTTCGTCCAC CCTTCTCCGTCGTGTTCTCT 150
Interleukin 6 IL6 TGCCACCTCAGACAAAATGC AGGTTCAGGTTGTTTTCTGCC 159
Interleukin 10 IL10 GTCCGACTCAACGAAGAAGG GCCAGGAAGATCAGGCAATA 73
Interleukin 12 IL12 TCCTGGGAAAGTCCTGTCGT GGTGAGGTCGCTAGTTTGGA 81
Interleukin 17 IL17 GCACACGGGCTGCATCAACG TGCAACCAACAGTGACCCGCA 149
Myeloperoxidase MPO CCCGAGTTGCTTTCCTCACT AAGAAGGGGATGCAGTCACG 127
Pyruvate dehydrogenase α1 PDHA1 GTCAGGAAGCTTGTTGCGTG GGTAAAGCCATGAGCTCGGT 86
Pyruvate kinase PKM GCCCTGGACACTAAAGGACC CAGCCACAGGACATTCTCGT 147
Peroxisome proliferator activated receptor alpha PPARA CCGAGACCGCAGATCTCAAG GACGAAAGGCGGGTTATTGC 128
RAR-related orphan receptor alpha RORrt CAGCGCTCCAACATCTTCTC GACCAGCACCACTTCCATTG 207
S100 Calcium Binding Protein A9 S100A9 GCCAAACTTTCTCAAGAAGCA AGTGTCCAGGTCTTCCAGGAT 70
T-Box transcription factor TBET CTGAGAGTCGCGCTCAACAA ACCCGGCCACAGTAAATGAC 121
Transforming growth factor beta 1 TGFB1 GCAAGGTCCTGGCTCTGTA TAGTACACGATGGGCAGTGG 97
Toll-like receptor 2 TLR2 CGTGTGCTATGACGCTTTCG GTACTTGCACCACTCGCTCT 232
Toll-like receptor 4 TLR4 TGGTGTCCCAGCACTTCATA CAACTTCTGCAGGACGATGA 116
Tumor necrosis factor alpha TNFA ATTCAGGGATGTGTGGCCTG CCAGATGTCCCAGGTTGCAT 120
Kruskal Wallis’ test. In Exp 1 differences between FGR and
NBW animals in gene expression were assessed separately
with or without LPS stimulation. Afterwards the effect of LPS
stimulations was determined by a similar model using LPS as the
fixed factor and the individual pigs as the random factor. In Exp 2,
within the animals inoculated with SE we first tested the effect of
FGR, separately for each post inoculation time point. To elucidate
the effect of SE inoculation we compared all SE infused animals
(both FGR and NBW) to all saline infused animals (CON). One
litter (n = 24) was removed from this comparison as it only
included SE infused pigs and no saline infused control group.
In Exp 3 we first tested the effects of FGR on bone marrow
infection and blood endpoints separately in antibiotic and non-
antibiotic treated preterm pigs at each postnatal time point. The
gene expression analysis on day 5 and 9 was assessed in the same
manner as in Exp 1.
RESULTS
Impaired Immune Competence in FGR Pigs
at Birth Assessed by Cord Blood LPS
Stimulation
In Exp 1, the mean birth weight was lower in the FGR group
compared to the NBW (723 ± 30 vs. 1,119 ± 19 g, P < 0.001).
Before LPS stimulation in cord blood, FGR preterm pigs showed
diminished expression of TBET and SA100A9 as well slightly
higher expression of IL4 (P < 0.01, 0.001, and 0.05, respectively,
Figures 1A–C). After LPS stimulation, the FGR group showed
lower expression of TNFA, IL6 and TLR2 (P < 0.01, 0.001, and
0.05, respectively, Figures 1A–C), with tendencies toward lower
expression of IL4 (P = 0.07, Figure 1B), relative to NBW pigs. In
the FGR group, LPS stimulation increased expression of TBET,
IL6, IL10, TLR2, TLR4, and S100A9 (all P < 0.05, Figures 1A–C),
with tendencies toward higher expression of TNFA and CXCL10
(P = 0.09 and 0.06, respectively, Figures 1A,C) and lower
expression of GATA3 (P = 0.06, Figure 1B). Within the NBW
group, LPS stimulation increased expression of TNFA, IL6,
IL10, TLR2, TLR4, S100A9, CXCL9, and CXCL10 (all P < 0.01,
Figures 1A–C) and diminished expression of TBET, IL2 and IL4
(P < 0.05, 0.05, and 0.01, respectively, Figures 1A,B). There
was also a tendency toward less expression of IL12 (P = 0.07,
Figure 1A).
For genes related to cellular metabolism, FGR pigs showed
lower expression of PPARA and PKM before LPS stimulation (all
P < 0.01, Figure 1D), with a tendency toward lower expression
ofHIF1A and TGFB (P = 0.08 and 0.07, respectively, Figure 1D)
than NBW pigs. After LPS stimulation, the FGR group still
showed lower expression of PPARA and PKM (all P < 0.05,
Figure 1D) and a tendency toward lower expression of HIF1A
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FIGURE 1 | Cord blood leucocyte gene expressions in normal birth weight (NBW, n = 60) and fetal growth restricted (FGR, n = 21) preterm pigs. Expression of (A)
Th1 and Th17–, (B) Th2–, (C) innate immunity-, and (D) cellular metabolism-related genes. Data are shown as fold changes in relation to housekeeping gene, all
presented on a logarithmic scale, before and after stimulation with lipopolysaccharide (LPS). Data are presented as means with corresponding standard error. *:
Difference between NBW and FGR; (*) P < 0.1, *P < 0.05, **P < 0.01, ***P < 0.001. §: Effect of LPS stimulation; (§)P < 0.1, §P < 0.05, §§P < 0.01, §§§P < 0.001.
and TGFB (both P = 0.07, Figure 1D). Within the NBW group,
LPS stimulation lead to lower expression of PADHA1 and PKM
(all P< 0.05, Figure 1D).Within the FGR group, LPS stimulation
did not affect the expression of any metabolism related gene.
Severe Sepsis Outcomes in Newborn
Preterm FGR Pigs Following SE Infection
In Exp 2, the mean birth weight was lower in SE-FGR
than SE-NBW (701 ± 38 vs. 993 ± 34 g, P < 0.001). The
overall birth weight did not differ between SE inoculated
animals and CON (data not shown). Following SE infusion, SE
inoculated pigs showed septic responses with lower blood pH
and higher blood carbon dioxide pressure at 6 and 12 h (all P
< 0.01, Figures 2A,B), and higher bicarbonate levels and lower
oxygen pressure at 12 h after inoculation (P < 0.05 and 0.001,
respectively, Figures 2C,F). Relative to SE-NBW pigs, SE-FGR
preterm pigs had lower blood pH 6 h after inoculation with
corresponding higher carbon dioxide pressure (all P < 0.01,
Figures 2A,B). After 12 h, pH was still lower in SE-FGR with
higher bicarbonate and lactate levels (Figures 2A,C,E). Blood
glucose levels were consistently higher in SE-FGR than SE-NBW
pigs at both 6 and 12 h (P < 0.05, Figure 2F).
For the cellular immune parameters, relative to controls,
SE infected pigs experienced depletion of blood neutrophils,
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FIGURE 2 | Blood gas parameters in normal birth weight and fetal growth restricted preterm pigs inoculated with live Staphylococcus epidermidis (SE-NBW, n = 29
and SE-FGR, n = 9, respectively), as well as preterm pigs inoculated with control saline (CON, n = 19). (A) Blood pH. (B) Blood carbondioxide pressure. (C) Blood
levels of bicarbonate. (D) Blood levels of lactate. (E) Blood glucose levels. (F) Blood oxygen pressure Data are presented as means with corresponding standard error,
6 and 12 h after inoculation. #: Difference between all SE inoculated preterm pigs and CON; #P < 0.05, ##P < 0.01, ###P < 0.001. *: Difference between
SE-NBW and SE-FGR; *P < 0.05, **P < 0.01, ***P < 0.001.
lymphocytes, and monocytes at 6 and 12 h (all P < 0.001,
Figures 3A,B,D) with lower platelet counts only at 12 h (P <
0.001, Figure 3B). Relative to SE-NBWpigs, SE-FGR pigs showed
blood lower neutrophil and platelet counts after 12 h (P < 0.05
and 0.001, respectively, Figures 3A,B). Blood lymphocyte and
monocyte counts were higher in SE-FGR vs. SE-NBW pigs after 6
and 12 h (all P < 0.05, respectively, Figure 3C). The full panel of
hematological parameters at 6, 12, and 24 h after inoculation was
shown in Supplementary Table 1.
Impaired Immune Competence and
Increased Nosocomial Infection in
Neonatal Preterm FGR Pigs
In Exp 3, the overall birth weight were significantly lower
in FGR than NBW animals (740 ± 30 vs. 1,141 ± 19 g, P
< 0.001). At euthanasia on day 9, FGR-CON pigs showed a
higher incidence of spontaneous aerobic bacterial infection of
the bone marrow than their NBW-CON counterparts (P <
0.05, Figure 4A). The effect was still significant when comparing
all FGR preterm pigs to all NBW (95 vs. 67%, Fisher’s exact
test: P < 0.01). The density of aerobic bacteria in the bone
marrow was higher in FGR-CON pigs compared to NBW-
CON (P < 0.01), but not in FGR-AB compared to NBW-
AB (Figure 4B). When comparing all pigs, FGR preterm pigs
had higher densities of aerobic bacteria in the bone marrow
compared to NBW (3.9 vs. 2.6 × 109 CFU/ml, P < 0.01). The
incidence of anaerobic bacterial infection in bone marrow did
not differ between groups (Figure 4C). However, the density of
anaerobically cultured bacteria was higher in FGR-CON than
NBW-CON (P < 0.05, Figure 4D). The dominant strains of
aerobically cultured bacteria isolated from the bone marrow are
shown in Figure 4E with the dominance of Enterococcus and
Staphyloccocus spp.
For hematological parameters, FGR-CON pigs showed higher
blood neutrophil counts on day 5 than NBW-CON (P <
0.05, Figure 5A). On day 9, FGR-CON still had higher blood
neutrophil counts than NBW-CON, but FGR-AB had lower
neutrophil counts thanNBW-AB (all P< 0.05, Figure 5A). Blood
neutrophil phagocytosis function was also affected, as FGR-AB
treated pigs had a lower phagocytic rate on both day 5 and 9
(P < 0.01 and 0.001, respectively), with a correspondingly lower
phagocytic capacity only on day 5 (P < 0.05, Figures 5B,C).
When comparing all FGR pigs to all NBW, only the phagocytic
rate at day 5 differed, being lower in FGR pigs (85 ± 4 vs. 91
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FIGURE 3 | Hematological parameters in normal birth weight and fetal growth restricted preterm pigs inoculated with live Staphylococcus epidermidis (SE-NBW, n =
29 and SE-FGR, n = 9, respectively), as well as preterm pigs inoculated with control saline (CON, n = 19). (A–D) Blood neutrophil, lymphocyte, platelet, and
monocyte counts. Data are presented as means with corresponding standard error, 6 and 12 h after inoculation. #: Difference between all SE inoculated preterm pigs
and CON. ##P < 0.01, ###P < 0.001. *: Difference between SE-NBW and SE-FGR; *P < 0.05, **P < 0.01, ***P < 0.001.
± 1%, P < 0.01). Blood platelet counts were lower in FGR-
CON than NBW-CON on day 5, but higher on day 7 (P < 0.05,
Figure 5D). For FGR-AB, the platelets counts were lower on day
7 and 9 than in NBW-AB (all P < 0.05, Figure 5D). For blood
T cell subsets in non-antibiotics treated animals, the fraction
of regulatory T cells was higher on day 7 in the FGR-CON
group relative to NBW-CON (P < 0.05). In antibiotics treated
animals, FGR-AB had increased fractions of both CD4 positive
and regulatory T cells on days 5, 7, and 9 compared to NBW-AB
(P < 0.05, except CD4 positive T cells on day 5 and regulatory
T cells on day 9, P < 0.01, Figures 5E,F). In addition, the ratio
of CD4 to CD8 positive T cells was increased in FGR-AB pigs,
compared to NBW-AB on day 9 (9.2 ± 1.1 vs. 5.8 ± 0.6, P <
0.001). Besides these findings, FGR pigs showed higher levels
of total leucocytes, red blood cells, and hematocrit over the
course of the experiment, compared to their NBW counterparts
(Supplementary Table 2).
Gene expression analysis after blood stimulation on day 5
and 9 was performed to support the hematological and T cell
findings (Figures 6A–F). On day 5, baseline gene expressions
did not differ between FGR-CON and NBW-CON or FGR-AB
or NBW-AB. After stimulation with LPS, expressions of TLR2,
TLR4, and CXCL9 were increased only in NBW-CON pigs, but
not FGR-CON (all P < 0.05, Figures 6A–C). For these same
genes, LPS effects were similar in FGR-AB and NBW-AB pigs.
Only TBET was expressed slightly more in FGR-AB pigs after
LPS stimulation, than in NBW-AB (P < 0.01, Figure 6E). By
day 9, the baseline expression of TLR2 was higher in FGR-CON
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FIGURE 4 | Spontaneous bacterial infection of the bone marrow of normal birth weight or fetal growth restricted preterm pigs, reared for 9 days, receiving either
antibiotics (NBW-AB, n = 22 and FGR-AB, n = 8) or not (NBW-CON, n = 78 and FGR-CON, n = 19). (A) Incidence of aerobically cultured bacterial growth in the
bone marrow. (B) Density of aerobically cultured bacteria in the bone marrow. (C) Incidence of anaerobically cultured bacterial growth in the bone marrow. (D) Density
of anaerobically cultured bacteria in the bone marrow. (E) Distribution of dominant aerobically cultured bacterial strains. (A,C) Presented as fraction of animals with
bacterial growth. (B,D) Presented as means with corresponding standard error. (E) Each bacterial group, shown as a fraction of the whole. *: Difference between
either NBW-CON and FGR-CON or NBW-AB and FGR-AB; *P < 0.05, **P < 0.01.
pigs than NBW-CON (P < 0.05, Figure 6A) but tended to be
lower for CXCL9 (P= 0.07, Figure 6C). Furthermore, FGR-CON
pigs were not able to mount expressions of TLR2 and TLR4
after stimulation with LPS, whereas NBW-CON pigs were more
competent (P < 0.01 and 0.001, respectively, Figures 6A,B).
Baseline expression of genes did not differ between FGR-AB and
NBW-AB on day 9. However, after stimulation with LPS, FGR-
AB pigs showed lower expression of TLR2, CXCL9, CXCL10,
and TBET than NBW-AB (all P < 0.05, Figures 1A,C–E) with
a tendency toward lower expression of TLR4 and IL10 (P = 0.07
and 0.06, respectively, Figures 6B,F). Likewise, the FGR-AB pigs
did not increase expression of IL10 after LPS stimulation, whereas
NBW-AB did (P < 0.01, Figure 6F). For the remaining tested
genes, there were no or minor differences among the groups
(Supplementary Table 3).
DISCUSSION
Following preterm birth, immune status, and infection resistance
during the first days and weeks of life are critical factors for
survival and long-term health. We show that preterm pigs
born following fetal growth-restriction, show clear evidence of
impaired immune competence in the critical neonatal period,
with adverse clinical outcome after infection challenge and an
increased rate of spontaneous infections. Interestingly, the effects
of being born growth restricted were in part exacerbated by
antibiotic use in the immediate postnatal period, although more
studies are required to confirm this and investigate mechanisms.
Collectively, our data help to explain why infants born both
premature and SGA have increased morbidity and mortality.
Although antibiotics seemed to reduce bacterial densities in bone
marrow, the results suggest a need for increased critical care, but
also cautious antibiotics use, for this special subpopulation of
preterm newborn infants.
Cord blood of FGR and NBW pigs was initially used
to examine immune competence at birth by a whole blood
stimulation assay with LPS. Before LPS stimulation, FGR preterm
pigs showed lower baseline expressions of few genes, However,
we did not measure the leucocyte levels in Exp 1, but we have
previously shown that FGR piglets tend to have lower lymphocyte
counts (but not neutrophil and monocyte counts) in cord blood
(10). Therefore, it is possible that differences in expressions of
some lymphocytes-related genes at baseline may be influenced by
the leucocyte levels. Still, after stimulation with LPS, it appeared
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FIGURE 5 | Blood immune cell subsets of normal birth weight or fetal growth restricted preterm pigs, reared for 9 days, receiving either antibiotics (NBW-AB, n =
13–19 and FGR-AB, n = 5–7) or not (NBW-CON, n = 47–54 and FGR-CON, n = 12–14). (A) Blood neutrophil counts. (B) Neutrophil phagocytic rate. (C) Neutrophil
phagocytic capacity. (D) Blood platelets counts. (E) Fraction of CD4 positive T cells, as a percentage of all T cells. (F) Fraction of regulatory T cells, as a percentage of
CD4 positive T cells. Data are presented as means with corresponding standard error, 5, 7, and 9 days after birth. *: Difference between either NBW-CON and
FGR-CON or NBW-AB and FGR-AB; (*)P < 0.1, *P < 0.05, **P < 0.01, ***P < 0.001.
that blood leucocytes of FGR animals had a diminished response
with regards to several genes related to innate and adaptive
immunity as well as cellular metabolism. This indicates an overall
impaired capacity to mount sufficient immune response to
infectious challenges in newborn preterm pigs with fetal growth
restriction. This is similar to the diminished immune function at
birth observed in cord blood of SGA preterm infants (17).
To be able to relate the ex vivo immune response to the
actual infection outcomes in FGR preterm pigs, we performed
an in vivo infection challenge with systemic administration of
SE to induce neonatal sepsis (Exp 2), in a similar manner to
previous studies (29). SE is normally considered a low virulent
pathogen and was previously often considered a contamination
if cultured from the blood (33). However, coagulase negative
staphylococci, like SE, are among the most common organism
isolated from preterm infants with LOS (3, 34). As expected,
SE infected pigs appeared to undergo respiratory acidosis 6 h
after infusion (low blood pH and oxygen pressure with high
carbon dioxide pressure), similar to what have been observed in
preterm infants with neonatal sepsis (35). The overall effects of
SE challenge, when compared to saline infused pigs (drop in pH
and leucocyte subsets after SE inoculation), were also similar to
those that we have observed in previous experiments, using the
same model (29). This confirms that pigs underwent a relevant
immunological challenge. Interestingly, SE infected FGR animals
showed more severe clinical and cellular responses, relative to
their littermates of adequate birth weight. Their drop in blood
pH and bicarbonate was followed by a corresponding rise in
lactate, indicating that the FGR preterm pigs were undergoing
a more severe septic response to the SE challenge. This was
also accompanied by a more severe drop in neutrophils and
platelets in SE-FGR pigs. Collectively, it was clear that newborn
growth restricted preterm pigs were more affected by the SE
inoculation than their preterm normal birth weight counterparts.
The combined data in Exp 1 and 2 suggest that infants born
with prematurity and fetal growth restriction have impaired
immune competence that may lead to higher susceptibility to
neonatal sepsis following systemic infection, in the immediate
neonatal period.
We also attempted to characterize the immune development
and test the susceptibility to spontaneous infection, over the first
few days after preterm birth in FGR pigs. It was evident that
FGR preterm pigs, were more prone to infection of aerobically
cultured bacteria in their bone marrow, with higher densities
of bacteria than pigs of adequate birth weight. The effect was
less apparent for antibiotics treated pigs that showed bacterial
densities comparable to the NBW-CON pigs. For anaerobically
cultured bacteria there were no effects, possibly a result of
the high blood flow in the bone marrow, somewhat restricting
anaerobic bacterial growth. In fact, very few strictly anaerobic
bacteria could be cultured (data not shown). The species of
aerobically cultured bacteria found in the bone marrow are all
known to inhabit the gut of preterm infants and pigs (34, 36).
This indicates that preterm SGA infants may be either more
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FIGURE 6 | Blood leucocyte gene expressions of normal birth weight or fetal growth restricted preterm pigs, reared for 9 days, receiving either antibiotics (NBW-AB,
n = 8–17 and FGR-AB, n = 2–5) or not (NBW-CON, n = 14–22 and FGR-CON, n = 3). (A–F) Expression of TLR2, TLR4, CXCL9, CXCL10, TBET, and IL10. Data are
presented as means with corresponding standard error, 5 and 9 days after birth. *: Difference between either NBW-CON and FGR-CON or NBW-AB and FGR-AB; (*):
P < 0.1, *P < 0.05, **P < 0.01. §: Effect of LPS stimulation; (§):P < 0.1, §P < 0.05, §§P < 0.01, §§§P < 0.001.
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prone to bacterial translocation across the gut or have a reduced
capacity to clear the gut derived systemic bacteria. In this study,
we have not investigated gut permeability per se, so differentiating
between the two factors is difficult. The supporting data showed
that over the first week of life, FGR preterm pigs consistently had
poorer systemic immune functions and an immune suppressed
status, with less capacity to response to an ex vivo challenge.
The development of immune cell subsets, including T cell
subsets, was affected by neonatal antibiotic treatment, as expected
(24). Interestingly though, adverse immune effects of being born
FGR were more pronounced in animals treated with antibiotics.
The FGR-AB preterm pigs showed lower neutrophil counts
with poorer phagocytosis capacity, as well as higher fractions
of CD4 positive and regulatory T cells, relative to NBW-AB.
The FGR-CON pigs also showed higher counts of regulatory
T cells on day 7, indicating the effect of low birth weight
was not entirely dependent on antibiotics. These results suggest
that FGR preterm pigs, irrespective of antibiotic treatment, had
decreased immune function, relative to their NBW counterparts.
The whole blood LPS stimulation assays could support this
conclusion in that blood leucocytes of FGR-AB pigs expressed
less TBET than NBW-AB pigs, indicating that the increased
number of CD4 positive T cells in FGR-AB pigs were skewed
toward a Th2 phenotype. As in Exp 1, the baseline leucocyte
gene expression levels could be influenced by the differences in
neutrophil counts observed. However, several innate immune
related genes were also expressed less in FGR-AB and FGR-CON
pigs following LPS stimulation than in their NBW counterparts.
The increased fraction of regulatory T cells may act to dampen
the immune competence or delay immune maturation in FGR
preterm pigs. This immune suppressive status may lead to less
systemic bacterial clearance and more bacterial accumulation
in the bone marrow of FGR preterm pigs. However, these
longer term immune effects are more suggestive and require
further exploration.
Interestingly, in Exp 1, we found that cord blood leucocytes of
newborn growth restricted preterm pigs had a lower expression
of genes related to cellular energy metabolism (PPARA, HIF1A,
and PKM), both before and after LPS stimulation. The PPARA
gene encodes the protein peroxisome proliferator–activated
receptor α, which is crucial for fatty acid metabolism and
ketogenesis (37). The gene is mostly expressed in hepatocytes,
where it plays a major role in fasting responses (38). However,
higher levels of peroxisome proliferator–activated receptors
in monocytes has been linked to anti-inflammatory cytokine
production and differentiation to macrophages (39–41) as well
as increased activity of cellular fatty acid oxidation and oxidative
phosphorylation (42). Pyruvate kinase (encoded by PKM) is
a glycolytic enzyme crucial for the generation of adenosine
triphosphate (ATP), the last step of the glycolysis process,
normally occurring under anaerobic conditions (43). However,
it is well-established that pro-inflammatory leucocytes rely on
glycolysis to exude their function, even when oxygen is abundant,
a phenomenon known as the Warburg effect (44, 45). Hypoxia-
inducible factor-1a (encoded by HIF1A) is also a regulator
in glycolysis and has been proposed as a mediator of the
Warburg effect (46, 47) via the mTOR immune pathway and
therefore can also be considered an immune related factor (48,
49). The drop in expressions of PKM, HIF1A, and PPARA in
Exp 1 may reflect less ATP production, possibly due to lower
energy reservoirs, and therefore could impair energy-consuming
immune responses in the FGR preterm pigs. This observation
was similar to the poor immune responses and low expressions
of monocyte genes related to both glycolysis and oxidative
phosphorylation in preterm vs. term infants (50). Further,
following SE inoculation in Exp 2, the FGR pigs had higher
glucose levels, which could indicate a dysregulated metabolism
during infections or endogenous glucose generation associated
with more excessive inflammatory response. This could possibly
be part of the explanation for their poorer outcome, compared
to NBW preterm piglets subjected to the same experimental
SE inoculation.
Preterm pigs have emerged as good models for preterm
infants, with many similarities in size, physiology, and immune
system (27, 32). Due to the large litter sizes of pigs there
is a sizable variation in birth weight, making it possible to
compare low and high birth weight individuals (51). The
causes of this birth weight variation may be a combination
of placental variation in blood flow and intrinsic fetal genetic
determinants. In humans, the causes leading to slow intrauterine
growth are more diverse, including other associated pathologies,
like maternal infections and preeclampsia playing a role (52).
These conditions could separately affect postnatal immune
development, regardless of birth weight. Using elective cesarean
section of preterm pigs from uncomplicated sow pregnancies, we
can study the effects of fetal growth restriction, independent of
such inflammatory and pathological maternal conditions, leading
to preterm birth with/without SGA in infants. Since there were no
prenatal complications prior to delivery of piglets, the observed
immunity effects in this study are likely to arise from slow
intrauterine growth per se, independent of any fetal or maternal
inflammatory or pathological conditions.
We conclude that there are clear effects on the neonatal
immune system of being born SGA after preterm birth, with
greater sensitivity and adverse response to bacterial infection,
less responsive leucocytes in vitro, and increased fraction of
regulatory T cells. Collectively, our results suggest that preterm
pigs born moderately growth restricted were immune suppressed
or experienced some delay in immune maturation, which may
be further exacerbated by neonatal antibiotic use. Such effects
may be most pronounced in the immediate neonatal period
(e.g., the first 1–2 weeks), as supported by the limited effects of
moderate FGR and prematurity on blood immune parameters
(10, 53) and gut and brain development beyond the first 2 weeks
of life (53, 54). Correspondingly, a dysfunctional immune system
and an increased risk of infections in preterm infants with fetal
growth restriction suggest special care and medical attention
in this population to avoid damaging infections in the critical
neonatal period.
DATA AVAILABILITY STATEMENT
The raw data supporting the conclusions of this article will be
made available by the authors, without undue reservation.
Frontiers in Immunology | www.frontiersin.org 11 August 2020 | Volume 11 | Article 1808
Bæk et al. Immunity After Fetal Growth Restriction
ETHICS STATEMENT
The animal study was reviewed and approved by Danish National
Committee on Animal Experimentation (2014-15-0201-00418).
AUTHOR CONTRIBUTIONS
DN designed the study. DN, AB, and SR carried out the
experiments and laboratory analysis. OB performed data analysis
and wrote the manuscript. OB, SR, AB, PS, and DN provided
critical interpretation and revised the manuscript. OB and DN
had primary responsibility for the final content. All authors
approved the final paper.
ACKNOWLEDGMENTS
We would like to thank Thomas Thymann, Yanqi Li, Xiaoyu
Pan, Elin Skytte, Jane C. Povlsen, and Kristina Møller
for their help performing these experiments. This study
was supported by NEOCOL project funded by Innovation
Foundation Denmark.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fimmu.
2020.01808/full#supplementary-material
REFERENCES
1. Fanaroff AA, Korones SB, Wright LL, Verter J, Poland RL, Bauer CR,
et al. Incidence, presenting features, risk factors and significance of late
onset septicemia in very low birth weight infants. the national institute
of child health and human development neonatal research network.
Pediatr Infect Dis J. (1998) 17:593–8. doi: 10.1097/00006454-199807000-
00004
2. el Manouni el Hassani S, Berkhout DJC, Niemarkt HJ, Mann S, de Boode
WP, Cossey V, et al. Risk factors for late-onset sepsis in preterm
infants: a multicenter case-control study. Neonatology. (2019) 116:42–
51. doi: 10.1159/000497781
3. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA,
et al. Late-onset sepsis in very low birth weight neonates: the experience
of the NICHD neonatal research network. Pediatrics. (2002) 110:285–
91. doi: 10.1542/peds.110.2.285
4. Strunk T, Currie A, Richmond P, Simmer K, Burgner D. Innate immunity in
human newborn infants: prematurity means more than immaturity. J Matern
Neonatal Med. (2011) 24:25–31. doi: 10.3109/14767058.2010.482605
5. Kristensen S, Salihu HM, Keith LG, Kirby RS, Fowler KB, Pass MAB. SGA
subtypes and mortality risk among singleton births. Early Hum Dev. (2007)
83:99–105. doi: 10.1016/j.earlhumdev.2006.05.008
6. Watts T, Roberts I. Haematological abnormalities in the growth-restricted
infant. Semin Neonatol. (1999) 4:41–54. doi: 10.1016/S1084-2756(99)80006-2
7. Li J, Li H, Mao H, Yu M, Yang F, Feng T, et al. Impaired NK cell
antiviral cytokine response against influenza virus in small-for-gestational-age
neonates. Cell Mol Immunol. (2013) 10:437–43. doi: 10.1038/cmi.2013.31
8. Ferguson AC. Prolonged impairment of cellular immunity in
children with intrauterine growth retardation. J Pediatr. (1978)
93:52–56. doi: 10.1016/S0022-3476(78)80599-X
9. McDade TW, Beck MA, Kuzawa CW, Adair LS. Prenatal undernutrition
and postnatal growth are associated with adolescent thymic function. J Nutr.
(2001) 131:1225–31. doi: 10.1093/jn/131.4.1225
10. Bæk O, Sangild PT, Thymann T, Nguyen DN. Growth restriction and
systemic immune development in preterm piglets. Front Immunol. (2019)
10:2402. doi: 10.3389/fimmu.2019.02402
11. Amdi C, Lynegaard JC, Thymann T, Williams AR. Intrauterine growth
restriction in piglets alters blood cell counts and impairs cytokine responses
in peripheral mononuclear cells 24 days post-partum. Sci Rep. (2020)
10:4683. doi: 10.1038/s41598-020-61623-w
12. Hu L, Peng X, Chen H, Yan C, Liu Y, Xu Q, et al. Effects of
intrauterine growth retardation and Bacillus subtilis PB6 supplementation
on growth performance, intestinal development and immune function
of piglets during the suckling period. Eur J Nutr. (2017) 56:1753–
65. doi: 10.1007/s00394-016-1223-z
13. Han F, Hu L, Xuan Y, Ding X, Luo Y, Bai S, et al. Effects of high nutrient intake
on the growth performance, intestinal morphology and immune function
of neonatal intra-uterine growth-retarded pigs. Br J Nutr. (2013) 110:1819–
27. doi: 10.1017/S0007114513001232
14. Tröger B, Göpel W, Faust K, Müller T, Jorch G, Felderhoff-Müser U,
et al. Risk for late-onset blood-culture proven sepsis in very-low-birth
weight infants born small for gestational age: a large multicenter study
from the German neonatal network. Pediatr Infect Dis J. (2014) 33:238–
43. doi: 10.1097/INF.0000000000000031
15. Zeitlin J, El Ayoubi M, Jarreau PH, Draper ES, Blondel B,
Künzel W, et al. Impact of fetal growth restriction on mortality
and morbidity in a very preterm birth cohort. J Pediatr. (2010)
157:733–9.e1. doi: 10.1016/j.jpeds.2010.05.002
16. Bernstein IM, Horbar JD, Badger GJ, Ohlsson A, Golan A. Morbidity and
mortality among very-low-birth-weight neonates with intrauterine growth
restriction. the vermont oxford network. Am J Obstet Gynecol. (2000)
182:198–206. doi: 10.1016/S0002-9378(00)70513-8
17. Tröger B, Müller T, Faust K, Bendiks M, Bohlmann MK, Thonnissen
S, et al. Intrauterine growth restriction and the innate immune system
in preterm infants of ≤32 weeks gestation. Neonatology. (2013) 103:199–
204. doi: 10.1159/000343260
18. Vincent JL, Beumier M. Diagnostic and prognostic markers in sepsis. Expert
Rev Anti Infect Ther. (2013) 11:265–75. doi: 10.1586/eri.13.9
19. Hedegaard SS, Wisborg K, Hvas AM. Diagnostic utility of biomarkers
for neonatal sepsis - a systematic review. Infect Dis. (2015) 47:117–
24. doi: 10.3109/00365548.2014.971053
20. Ng PC, Ang IL, Chiu RWK, Li K, Lam HS, Wong RPO, et al. Host-response
biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis
in preterm infants. J Clin Invest. (2010) 120:2989–3000. doi: 10.1172/JCI40196
21. Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Empiric use of ampicillin
and cefotaxime, compared with ampicillin and gentamicin, for neonates at
risk for sepsis is associated with an increased risk of neonatal death. Pediatrics.
(2006) 117:67–74. doi: 10.1542/peds.2005-0179
22. Stoll BJ, Hansen NI, Higgins RD, Fanaroff AA, Duara S, Goldberg
R, et al. Very low birth weight preterm infants with early onset
neonatal sepsis: the predominance of gram-negative infections continues
in the national institute of child health and human development
neonatal research network, 2002-2003. Pediatr Infect Dis J. (2005) 24:635–
9. doi: 10.1097/01.inf.0000168749.82105.64
23. Nguyen DN, Fuglsang E, Jiang P, Birck MM, Pan X, Kamal SBS, et al. Oral
antibiotics increase blood neutrophil maturation and reduce bacteremia and
necrotizing enterocolitis in the immediate postnatal period of preterm pigs.
Innate Immun. (2016) 22:51–62. doi: 10.1177/1753425915615195
24. Fouhse JM, Yang K, More-Bayona J, Gao Y, Goruk S, Plastow G, et al.
Neonatal exposure to amoxicillin alters long-term immune response despite
transient effects on gut-microbiota in piglets. Front Immunol. (2019)
10:2059. doi: 10.3389/fimmu.2019.02059
25. Ni J, Friedman H, Boyd BC, McGurn A, Babinski P, Markossian T, et al.
Early antibiotic exposure and development of asthma and allergic rhinitis in
childhood. BMC Pediatr. (2019) 19:225. doi: 10.1186/s12887-019-1594-4
26. Tsakok T,McKeever TM, Yeo L, Flohr C. Does early life exposure to antibiotics
increase the risk of eczema? A systematic review. Br J Dermatol. (2013)
169:983–91. doi: 10.1111/bjd.12476
Frontiers in Immunology | www.frontiersin.org 12 August 2020 | Volume 11 | Article 1808
Bæk et al. Immunity After Fetal Growth Restriction
27. Sangild PT, Thymann T, Schmidt M, Stoll BJ, Burrin DG, Buddington RK.
The preterm pig as a model in pediatric gastroenterology. J Anim Sci. (2013)
91:4713–6359. doi: 10.2527/jas.2013-6359
28. Bæk O, Brunse A, Nguyen DN, Moodley A, Thymann T, Sangild PT. Diet
modulates the high sensitivity to systemic infection in newborn preterm pigs.
Front Immunol. (2020) 11:1019. doi: 10.3389/fimmu.2020.01019
29. Brunse A, Worsøe P, Pors SE, Skovgaard K, Sangild PT. Oral supplementation
with bovine colostrum prevents septic shock and brain barrier disruption
during bloodstream infection in preterm newborn pigs. SHOCK. (2018)
51:337–47. doi: 10.1097/SHK.0000000000001131
30. Li Y, Pan X, Nguyen DN, Ren S, Moodley A, Sangild PT. Bovine
colostrum before or after formula feeding improves systemic immune
protection and gut function in newborn preterm pigs. Front Immunol. (2020)
10:3062. doi: 10.3389/fimmu.2019.03062
31. Ren S, Hui Y, Goericke-Pesch S, Pankratova S, Kot W, Pan X, et al. Gut
and immune effects of bioactive milk factors in preterm pigs exposed to
prenatal inflammation. Am J Physiol - Gastrointest Liver Physiol. (2019)
317:G67–G77. doi: 10.1152/ajpgi.00042.2019
32. Nguyen DN, Jiang P, Frøkiær H, Heegaard PMH, Thymann T, Sangild PT.
Delayed development of systemic immunity in preterm pigs as a model for
preterm infants. Sci Rep. (2016) 6:36816. doi: 10.1038/srep36816
33. Padari H, Oselin K, Tasa T, Metsvaht T, Lõivukene K, Lutsar I. Coagulase
negative staphylococcal sepsis in neonates: do we need to adapt vancomycin
dose or target? BMC Pediatr. (2016) 16:206. doi: 10.1186/s12887-016-
0753-0
34. Graspeuntner S, Waschina S, Künzel S, Twisselmann N, Rausch TK,
Cloppenborg-Schmidt K, et al. Gut dysbiosis with bacilli dominance and
accumulation of fermentation products precedes late-onset sepsis in preterm
infants. Clin Infect Dis. (2019) 69:268–77. doi: 10.1093/cid/ciy882
35. Shane AL, Sánchez PJ, Stoll BJ. Neonatal sepsis. Lancet. (2017) 390:1770–
80. doi: 10.1016/S0140-6736(17)31002-4
36. Rasmussen SO, Martin L, Østergaard MV, Rudloff S, Li Y, Roggenbuck
M, Bering SB, et al. Bovine colostrum improves neonatal growth, digestive
function and gut immunity relative to donor human milk and infant formula
in preterm pigs. Am J Physiol - Gastrointest Liver Physiol. (2016) 311:G480–
91. doi: 10.1152/ajpgi.00139.2016
37. Desvergne B, Ijpenberg A, Devchand PR, Wahli W. The
peroxisome proliferator-activated receptors at the cross-road
of diet and hormonal signalling. J Steroid Biochem Mol Biol.
65:65–74. doi: 10.1016/S0960-0760(97)00182-9
38. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W.
Peroxisome proliferator-activated receptor α mediates the adaptive response
to fasting. J Clin Invest. (1999) 103:1489–98. doi: 10.1172/JCI6223
39. Jiang C, Ting AT, Seed B. PPAR-γ agonists inhibit production of monocyte
inflammatory cytokines. Nature. (1998) 391:82–86. doi: 10.1038/34184
40. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome
proliferator-activated receptor-γ is a negative regulator of
macrophage activation. Nature. (1998) 391:79–82. doi: 10.1038/
34178
41. Maess MB, Sendelbach S, Lorkowski S. Selection of reliable reference genes
during THP-1 monocyte differentiation into macrophages. BMC Mol Biol.
(2010) 11:90. doi: 10.1186/1471-2199-11-90
42. Harbeson D, Francis F, Bao W, Amenyogbe NA, Kollmann TR.
Energy demands of early life drive a disease tolerant phenotype and
dictate outcome in neonatal bacterial sepsis. Front Immunol. (2018)
9:1918. doi: 10.3389/fimmu.2018.01918
43. Meisenberg G. Principles of Medical Biochemistry. 2nd Edn. Philadelphia, PA:
Elsevier (2006).
44. Warburg O,Wind F, Negelein E. The metabolism of tumors in the body. J Gen
Physiol. (1927) 8:519–30. doi: 10.1085/jgp.8.6.519
45. Palsson-Mcdermott EM, O’Neill LAJ. The warburg effect then and
now: from cancer to inflammatory diseases. BioEssays. (2013) 35:965–
73. doi: 10.1002/bies.201300084
46. Larbi A, Zelba H, Goldeck D, Pawelec G. Induction of HIF-1alpha and the
glycolytic pathway alters apoptotic and differentiation profiles of activated
human T cells. J Leukoc Biol. (2010) 87:265–73. doi: 10.1189/jlb.0509304
47. Darekar S, Georgiou K, Yurchenko M, Yenamandra SP, Chachami G, Simos
G, et al. Epstein-Barr virus immortalization of human B-cells leads to
stabilization of hypoxia-induced factor 1 alpha, congruent with the warburg
effect. PLoS ONE. (2012) 7:e42072. doi: 10.1371/journal.pone.0042072
48. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, et al.
NF-κB links innate immunity to the hypoxic response through transcriptional
regulation of HIF-1α. Nature. (2008) 453:807–11. doi: 10.1038/nature06905
49. Wouters BG, Koritzinsky M. Hypoxia signalling through mTOR and the
unfolded protein response in cancer. Nat Rev Cancer. (2008) 8:851–
64. doi: 10.1038/nrc2501
50. Kan B, Michalski C, Fu H, Au HHT, Lee K, Marchant EA, et al. Cellular
metabolism constrains innate immune responses in early human ontogeny.
Nat Commun. (2018) 9:4822. doi: 10.1038/s41467-018-07215-9
51. Ferenc K, Pietrzak P, Godlewski MM, Piwowarski J, Kilianczyk R, Guilloteau
P, et al. Intrauterine growth retarded piglet as a model for humans – studies
on the perinatal development of the gut structure and function. Reprod Biol.
(2014) 14:51–60. doi: 10.1016/j.repbio.2014.01.005
52. Sankaran S, Kyle PM. Aetiology and pathogenesis of IUGR. Best Pract Res Clin
Obstet Gynaecol. (2009) 23:765–77. doi: 10.1016/j.bpobgyn.2009.05.003
53. Ren S, Hui Y, Obelitz-Ryom K, Brandt AB, Kot W, Nielsen DS, et al. Neonatal
gut and immune maturation is determined more by postnatal age than by
post-conceptional age in moderately preterm pigs. Am J Physiol Gastrointest
Liver Physiol. (2018) 315:G855–67. doi: 10.1152/ajpgi.00169.2018
54. Holme Nielsen C, Bladt Brandt A, Thymann T, Obelitz-Ryom K, Jiang P,
Vanden Hole C, et al. Rapid postnatal adaptation of neurodevelopment in pigs
born late preterm. Dev Neurosci. 40:586–600. doi: 10.1159/000499127
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Bæk, Ren, Brunse, Sangild and Nguyen. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution or reproduction in other forums is permitted, provided
the original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Immunology | www.frontiersin.org 13 August 2020 | Volume 11 | Article 1808
